Press Releases

MediPharm Labs Conditionally Approved to Graduate to the TSX

Jul 18, 2019

MediPharm Labs Provides Operational Update and Increases Average Weekly Production of Active Cannabinoid Component to 75 Million Milligrams

Jul 16, 2019

MediPharm Labs Secures 9,000 KG of Dried Cannabis Adding Substantial Private Label Cannabis Extract Production

Jun 27, 2019

MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

Jun 24, 2019

MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal

Jun 19, 2019

MediPharm Labs Announces Application to Upgrade Listing to the Toronto Stock Exchange

Jun 18, 2019

MediPharm Labs Announces Closing of $75 Million Bought Deal Financing

Jun 17, 2019

MediPharm Labs Corp. Announces Upsize of Bought Deal Financing to $75 Million

May 29, 2019

MediPharm Labs Announces $60 Million Bought Deal Equity Financing

May 28, 2019

UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And “CBD International Consortium” to Develop Treatment of Opioid Addiction

May 23, 2019